- Home
- DYAI vs GSIW Comparison
DYAI vs GSIW Comparison
Compare DYAI & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYAI
- GSIW
- Stock Information
- Founded
- DYAI 1979
- GSIW 2016
- Country
- DYAI United States
- GSIW Hong Kong
- Employees
- DYAI N/A
- GSIW N/A
- Industry
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- GSIW
- Sector
- DYAI Health Care
- GSIW
- Exchange
- DYAI Nasdaq
- GSIW Nasdaq
- Market Cap
- DYAI 29.6M
- GSIW 27.2M
- IPO Year
- DYAI 2004
- GSIW 2023
- Fundamental
- Price
- DYAI $1.00
- GSIW $1.53
- Analyst Decision
- DYAI Strong Buy
- GSIW
- Analyst Count
- DYAI 1
- GSIW 0
- Target Price
- DYAI $6.00
- GSIW N/A
- AVG Volume (30 Days)
- DYAI 38.9K
- GSIW 1.3M
- Earning Date
- DYAI 08-12-2025
- GSIW 12-31-2024
- Dividend Yield
- DYAI N/A
- GSIW N/A
- EPS Growth
- DYAI N/A
- GSIW N/A
- EPS
- DYAI N/A
- GSIW N/A
- Revenue
- DYAI $3,554,344.00
- GSIW $1,313,795.00
- Revenue This Year
- DYAI $22.56
- GSIW N/A
- Revenue Next Year
- DYAI $30.95
- GSIW N/A
- P/E Ratio
- DYAI N/A
- GSIW N/A
- Revenue Growth
- DYAI 57.59
- GSIW N/A
- 52 Week Low
- DYAI $0.91
- GSIW $0.35
- 52 Week High
- DYAI $2.20
- GSIW $12.30
- Technical
- Relative Strength Index (RSI)
- DYAI 49.34
- GSIW 77.76
- Support Level
- DYAI $0.95
- GSIW $1.39
- Resistance Level
- DYAI $1.06
- GSIW $1.58
- Average True Range (ATR)
- DYAI 0.06
- GSIW 0.17
- MACD
- DYAI 0.01
- GSIW 0.00
- Stochastic Oscillator
- DYAI 56.67
- GSIW 70.55
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.